文摘
Cefdaloxime (1a) is the bioactive principle of the1-(S)-(pivaloyloxy)ethyl ester prodrug HR916K (1b). Toprovidematerial for biological investigations a short and efficientlarge-scale synthesis of 1a was developed, which avoidschromatographic purification steps. Commercially available(6R,7R)-7-amino-3-(methoxymethyl)-3-cephem-4-carboxylic acid (AMCA)(2) is acylated with trityl-protectedmercaptobenzothiazolethioester in the presence of bis(trimethylsilyl)acetamide toyieldtritylated cefdaloxime. The trityl group is then removedbytreatment with formic acid, followed by pH-adjustedprecipitation of 1a. For a final purification, which has toconsidercefdaloxime specific side reactions, crude 1a is dissolvedindimethyl sulfoxide and precipitated with methanol toobtain1a in 66% overall yield on a kilogram scale.